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1. Introduction 
Mild proteolytic hydrolysis of the elongation fac- 
tor G splits it into a limited number of fragments 
[l-3]. Two fragments, Ta and T, (nomenclature 
from [2]) encompass the whole protein polypeptide 
chain. Fragment Tz represents the N-terminal part of 
the EF-G molecule with Mr 56 000 and fragment T5 
the C-terminal part withMr 25 000. In terms of gen- 
eral packing of their polypeptide chains, these frag- 
ments represent individual structural units or domains 
in the EF-G molecule [4]. 
The study of modification of tyrosine residues in 
EF-G [ 51 has shown that modification with either 
tetranitromethane or iodine inactivates the protein 
in the ribosome-dependent GTPase reaction. Tyrosine 
residues subjected to modification are located in the 
C-terminal domain (fragment Ts) and are effectively 
protected against modification by EF-G binding with 
the 70 S ribosome or the 50 S subparticle. In the 
presence of guanyl nucleotides whose binding site is 
located in the N-terminal domain (in the N-terminal 
part of fragment T,) [6] the rate of modification is 
considerably higher than in the free protein. Since 
modification of tyrosine residues does not affect the 
ability of EF-G to form binary complexes with guanyl 
nucleotides [ 51 and taking into account the shielding 
effect exerted by the ribosome on modification it has 
been concluded that the C-terminal domain contains 
one of the sites of interaction with the ribosome. It is 
possible that N- and C-terminal parts of EF-G inter- 
acting with GTP form a common site of interaction 
with the ribosome; this site disappears after GTP 
hydrolysis within the complex with the ribosome; as 
a result, EF-G loses affinity for the ribosome. 
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Here we report the results of the study of the pri- 
mary structure of fragment Tg. The polypeptide chain 
of the fragment consists of 228 ammo acid residues, 
does not contain tryptophan or cysteine residues. The 
C-terminal part of the fragment is two amino acid 
residues (Gly-Lys) shorter than the C-terminal part 
of EF-G. 
2. Materials and methods 
EF-G and fragment Ts were isolated as in [ 21. 
Homogeneity of the protein and fragment was 
checked by SDS-polyacrylamide gel electrophoresis 
and by determining the N-terminal ammo acid 
sequences by automatic Edman degradation. 
We have studied the products of fragment T, 
cleavage by cyanogen bromide, StaphyZococc~s 
uureus protease (Miles Lab.) and trypsin (TPCK- 
treated, Worthington) after modification of the frag- 
ment with maleic anhydride. To separate the mix- 
tures obtained we used gel filtration on Biogel P-10 or 
Sephadex G-25 with a following rechromatography of 
the fractions obtained on QAl-Sephadex A-25. To 
clarify the structure of large peptides of cyanogen 
bromide and tryptic hydrolysates, they were addi- 
tionally digested with trypsin, chymotrypsin and 
Stuphyloc0cc~s aureus protease. The mixtures 
obtained after hydrolysis were separared by the 
method of peptide mapping on cellulose thin-layer 
plates (Merck). The first dimension was electropho- 
resis for 1 h, 800 V (pH 3.5); the second dimension 
was chromatography in the system of solvents, 
n-butanol-pyridine-acetate-water (1: 1: 1: 1, by 
vol.), (PH 5.4). Paper chromatography (Whatman 
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(* Sequences determined by the automatic Edman method. 
(-) Sequences determined by the dansyl Edman method. 
Peptides obtained by additional cleavages of large fragments 
are not indicated in the scheme. 
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3 MM) in the same solvent system as for peptide 
mapping was also used to separate tryptic peptides. 
The peptides were localized with a 0.001% fluoresc- 
amine solution in acetone and eluted by 10% acetic 
or 85% formic acid. Reverse-phase chromatography 
on LiChrosorb RP-8 (10 pm) in an acetonitryl gra- 
dient was equally effective for separation of cyanogen 
bromide peptides. The column dimensions were 
4.6 X 250 mm: solution (A) 0.1 M ammonium ace- 
tate (pH 6.0), 5% acetonitryl; solution (B) 0.1 M 
ammonium acetate (pH 6.0) 50% acetonitryl. 
The C-terminal amino acid residues of fragment Ts 
and peptide CB-7 were determined using carboxy- 
peptidases A and B [7]. 
The amino acid composition was assessed on a 
D-500 amino acid analyzer (Durrum). The amount of 
valine and isoleucine was determined from the results 
of a 72-hour hydrolysis. 
Automatic determination of the amino acid 
sequence was carried out on a sequencer (model 
980 C, Beckman) using the dimethylallylamine pro- 
gram 102974 according to the company handbook 
and on a solid-phase sequencer APS-240 (Rank- 
Hilger). PTH-derivatives of amino acids were identi- 
fied by thin-layer chromatography on silica gel and 
HPLC (HP 1080 A chromatograph) on a Spherisorb 
RP-18 column (5 pm) in sodium phosphate buffer 
using a methanol gradient. 
The amino acid sequence of isolated peptides was 
determined by the dansyl Edman method [8]. Amino 
acid dansyl derivatives were identified by thin-layer 
chromatography on silica gel plates. Asparagine and 
glutamine were determined according to [9]. 
3. Results and discussion 
According to the data of SDS-polyacrylamide gel 
electrophoresis, fragment T5 has a Mr -25 000 and 
its amino acid composition was determined as fol- 
lows (in mol/%): 
Asp,7.33;Thr,3.59;Ser,4.66;Glr.t, 13.51;Pro, 
5.66; Gly, 10.64; Ala, 8.60; Val, 10.00; Met, 2.47; 
Ile, 4.62; Leu, 6.54; Tyr, 3.88; Phe, 3.11; His, 
1.95; Lys, 8.93; Arg, 4.31. 
Glutamine is the N-terminal amino acid and argi- 
nine is the C-terminal amino acid. 
The amino acid sequence up to position 32 inclu- 
sively was determined on a whole molecule by the 
automated liquid-phase Edman method. 
The molecule of fragment Ts contains 6 methio- 
nine residues, therefore 7 peptides resulted from 
cyanogen bromide cleavage (CB-l-7, scheme 1). The 
structure of peptides CB-2 and CB-3 was determined 
by the solid phase Edman method up to positions 29 
and 12, respectively. Peptides CB-3-7 were studied 
by the dansyl Edman method and the amino acid 
sequences were determined up to positions 12, 22, 15 
and 20, respectively. To clarify the complete amino 
acid sequences of cyanogen bromide peptides, we 
studied additionally the hydrolysates of peptide CB-1 
with trypsin and Staphylococcus aweus protease; 
those of peptide CB-2 with trypsin and chymotryp- 
sin; of peptide CB-4 with chymotrypsin; of peptides 
CB-5 and CB-6 with trypsin; of peptide CB-7 with 
thermolysine. As a result, we determined the com- 
plete amino acid sequences of 6 cyanogen bromide 
peptides, except for peptide CB-3 which was isolated 
in insufficient quantity. The structure of this frag- 
ment of the polypeptide chain was studied on peptide 
LT-5 isolated from tryptic hydrolysate of Ts modi- 
fied with maleic anhydride. This peptide encompasses 
almost completely the structure of peptides CB-3 and 
CB-4. The peptide was studied by the solid phase 
Edman method up to position 27 and then was sub- 
jected to chymotrypsin and thermolysine hydrolysis. 
As a result, we determined completely the structure 
of peptide CB-3 and obtained overlapping with pep- 
tide CB-4. To obtain peptides overlapping other 
cyanogen bromide fragments, we studied the remain- 
ing peptides of limited tryptic hydrolysate and prod- 
ucts of S. aureus protease hydrolysis. The structure of 
these peptides was mainly determined by the dansyl 
Edman method. 
Thus, the structure study of peptides isolated after 
digestion of the T5 molecule or its fragments by cyan- 
ogen bromide, trypsin, chymotrypsin, thermolysine 
and S. aureus protease gave the complete amino acid 
sequence of the C-terminal domain (fragment Ts) of 
EF-G (scheme 1). The poiypeptide chain consists of 
228 ammo a&d residues, the exact Mr is 25011.8 and 
the amino acid composition is as follows: 
Asp,,, As&, Thrs, Serra, Glurg, Glnrs, Prora, Gb24, 
AlaIs, Val22, Mete, Be,,, Leur4, Tyrre, Phes, Hiss, 
b318, k&O- 
We have shown [2] that all the fragments of lim- 
ited trypsinolysis of EF-G have arginine as the C-ter- 
minal amino acid while in EF-G the C-terminal amino 
acid is’lysine. Therefore it was necessary to determine 
by how many residues is fragment T5 shortened from 
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the C-terminus in comparison with EF-G. The study 
of products of cyanogen bromide cleavage of the 
whole EF-G molecule (to be published elsewhere) 
resulted in isolation of a peptide having a sequence 
analogous to that of the cyanogen bromide peptide 
(CB-7) of fragment T5 but differing from it by 2 amino 
acid residues Gly-Lys. Thus it has been concluded that 
limited EF-G trypsinolysis results in cleavage of a 
dipeptide from the C-terminus of fragment T5. The 
study of another EF-G cyanogen bromide peptide has 
shown that fragment T5 directly adjoins fragment Te. 
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